Braveheart Bio, Inc.
BRVE
$27.03
$1.064.08%
NASDAQ
Corporate Info
Website
Phone Number
415 707 6312
Address
One Letterman Drive
Building A
Suite A4-300
San Francisco, CA 94129
Building A
Suite A4-300
San Francisco, CA 94129
Country
United States
Year Founded
2024
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
--
Business Description
Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. It develops and offers BHB-1893 and HRS-1893, an oral small-molecule cardiac myosin inhibitor (CMI) for the treatment of obstructive HCM and non-obstructive HCM. The company was incorporated in 2024 and is headquartered in San Francisco, California.